Analyze Diet
Immunology1990; 71(4); 592-594;

Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.

Abstract: Equine-murine xenohybridoma cells were produced using SP2/0 murine myeloma cells and splenic lymph node cells obtained from horses infected with 10(6) TCID50 of single cloned variants of equine infectious anaemia virus (EIAV). The xenohybridomas secreted equine IgG monoclonal antibodies reactive with EIAV in enzyme immunoassays employing purified virus. Seven antibodies were studied in detail. They bound to viral glycoproteins (gp90 or gp45) in radioimmunoprecipitation assays, and reacted with homologous EIAV as well as five other cloned variants of EIAV. When evaluated against a single cloned variant of EIAV (EIAV-WSU5), two antibodies bound to different epitopes on gp90. The five remaining antibodies reacted with the same or overlapping epitopes on gp45. None of the antibodies exhibited viral neutralizing activity.
Publication Date: 1990-12-01 PubMed ID: 1703988PubMed Central: PMC1384884
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study focuses on creating equine antibodies that can identify common aspects of various strains of equine infectious anaemia virus, using xenohybridoma cells derived from horses and mice.

Creation of Xenohybridomas

  • The study produced xenohybridoma cells, which are hybrid cells combining equine (horse) and murine (mouse) elements. This was achieved by using the SP2/0 mouse myeloma cells and cells from the splenic lymph nodes of horses, which were infected with large quantities (10(6) TCID50) of individually cloned versions of EIAV.

Production of Equine Monoclonal Antibodies

  • The newly created xenohybridomas secreted equine IgG monoclonal antibodies. Researchers found that these antibodies reacted positively with EIAV when tested in enzyme immunoassays that utilized purified virus—implying these monoclonal antibodies have the capability to recognize and bind to the EIAV virus.

Antibody Interaction with Viral Glycoproteins

  • Scientists utilized radioimmunoprecipitation assays to analyze how the antibodies interacted with viral glycoproteins (proteins situated on the virus’ outer surface). They found that the antibodies adhered to two specific glycoproteins: gp90 and gp45.

Reactivity with Various EIAV Variants

  • The antibodies reacted not only with the specific EIAV variant they were derived from (homologous EIAV) but also with five other individually cloned EIAV variants. This implies a broad reactivity, as they can recognize common characteristics on multiple forms of the virus.

Precise Antibody Attachment Points

  • When tested against a specific variant of EIAV (EIAV-WSU5), two of the antibodies attached themselves to different areas (epitopes) on the gp90 glycoprotein. The other five antibodies bound to the same, or overlapping points on the gp45 glycoprotein.

Lack of Viral Neutralizing Activity

  • None of the seven antibodies studied demonstrated the ability to neutralize the virus. This means while these antibodies can recognize and bind to EIAV, they lack the ability to disable or destroy the virus.

Cite This Article

APA
Perryman LE, O'Rourke KI, Mason PH, McGuire TC. (1990). Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus. Immunology, 71(4), 592-594.

Publication

ISSN: 0019-2805
NlmUniqueID: 0374672
Country: England
Language: English
Volume: 71
Issue: 4
Pages: 592-594

Researcher Affiliations

Perryman, L E
  • Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
O'Rourke, K I
    Mason, P H
      McGuire, T C

        MeSH Terms

        • Animals
        • Antibodies, Monoclonal
        • Antigens, Viral / analysis
        • Enzyme-Linked Immunosorbent Assay
        • Epitopes / analysis
        • Horses
        • Hybridomas / immunology
        • Infectious Anemia Virus, Equine / immunology
        • Mice
        • Radioimmunoprecipitation Assay

        Grant Funding

        • AI 24166 / NIAID NIH HHS
        • AI 24291 / NIAID NIH HHS

        References

        This article includes 19 references
        1. Perryman LE, O'Rourke KI, McGuire TC. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.. J Virol 1988 Aug;62(8):3073-6.
        2. McGuire TC, Henson JB, Quist SE. Viral-induced hemolysis in equine infectious anemia.. Am J Vet Res 1969 Dec;30(12):2091-7.
          pubmed: 5389415
        3. Cheevers WP, McGuire TC. The lentiviruses: maedi/visna, caprine arthritis-encephalitis, and equine infectious anemia.. Adv Virus Res 1988;34:189-215.
          pubmed: 2843016doi: 10.1016/s0065-3527(08)60518-7google scholar: lookup
        4. Cheevers WP, McGuire TC. Equine infectious anemia virus: immunopathogenesis and persistence.. Rev Infect Dis 1985 Jan-Feb;7(1):83-8.
          pubmed: 2984759doi: 10.1093/clinids/7.1.83google scholar: lookup
        5. Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.. Arch Virol 1988;98(3-4):213-24.
          pubmed: 2450529doi: 10.1007/BF01322170google scholar: lookup
        6. Carpenter S, Evans LH, Sevoian M, Chesebro B. Role of the host immune response in selection of equine infectious anemia virus variants.. J Virol 1987 Dec;61(12):3783-9.
        7. O'Rourke KI, Perryman LE, McGuire TC. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.. Vet Immunol Immunopathol 1989 Nov 30;23(1-2):41-9.
          pubmed: 2559537doi: 10.1016/0165-2427(89)90108-6google scholar: lookup
        8. O'Rourke K, Perryman LE, McGuire TC. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus.. J Gen Virol 1988 Mar;69 ( Pt 3):667-74.
          pubmed: 3351480doi: 10.1099/0022-1317-69-3-667google scholar: lookup
        9. Wyatt CR, Magnuson NS, Perryman LE. Defective thymocyte maturation in horses with severe combined immunodeficiency.. J Immunol 1987 Dec 15;139(12):4072-6.
          pubmed: 3500980
        10. Montelaro RC, Parekh B, Orrego A, Issel CJ. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.. J Biol Chem 1984 Aug 25;259(16):10539-44.
          pubmed: 6206055
        11. Issel CJ, Adams WV Jr, Meek L, Ochoa R. Transmission of equine infectious anemia virus from horses without clinical signs of disease.. J Am Vet Med Assoc 1982 Feb 1;180(3):272-5.
          pubmed: 6276353
        12. Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses.. Virology 1980 Dec;107(2):520-5.
          pubmed: 6256947doi: 10.1016/0042-6822(80)90319-0google scholar: lookup
        13. McGuire TC, Perryman LE, Davis WC. Analysis of serum and lymphocyte surface IgM of healthy and immunodeficient horses with monoclonal antibodies.. Am J Vet Res 1983 Jul;44(7):1284-8.
          pubmed: 6410944
        14. McGuire TC, Crawford TB. Identification and quantitation of equine serum and secretory immunoglobulin A.. Infect Immun 1972 Oct;6(4):610-5.
          pubmed: 4117801doi: 10.1128/iai.6.4.610-615.1972google scholar: lookup
        15. Kono Y, Kobayashi K, Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses.. Arch Gesamte Virusforsch 1973;41(1):1-10.
          pubmed: 4123810doi: 10.1007/BF01249923google scholar: lookup
        16. Banks KL, Henson JB, McGuire TC. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus.. Lab Invest 1972 Jun;26(6):701-7.
          pubmed: 4337973
        17. McGuire TC, Crawford TB, Henson JB. Immunofluorescent localization of equine infectious anemia virus in tissue.. Am J Pathol 1971 Feb;62(2):283-94.
          pubmed: 4322275
        18. McGuire TC, Henson JB, Quist SE. Impaired bone marrow response in equine infectious anemia.. Am J Vet Res 1969 Dec;30(12):2099-104.
          pubmed: 5389416
        19. Payne SL, Fang FD, Liu CP, Dhruva BR, Rwambo P, Issel CJ, Montelaro RC. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV.. Virology 1987 Dec;161(2):321-31.
          pubmed: 2825406doi: 10.1016/0042-6822(87)90124-3google scholar: lookup

        Citations

        This article has been cited 3 times.
        1. Lonning SM, Zhang W, McGuire TC. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.. J Virol 1999 May;73(5):4257-65.
        2. Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.. J Virol 1999 Apr;73(4):2762-9.
        3. McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O'Rourke KI, Perryman LE. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.. J Virol 1994 Mar;68(3):1459-67.